Literature DB >> 30696898

Orthohantaviruses belonging to three phylogroups all inhibit apoptosis in infected target cells.

Carles Solà-Riera1, Shawon Gupta1,2, Hans-Gustaf Ljunggren1, Jonas Klingström3.   

Abstract

Orthohantaviruses, previously known as hantaviruses, are zoonotic viruses that can cause hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS) in humans. The HPS-causing Andes virus (ANDV) and the HFRS-causing Hantaan virus (HTNV) have anti-apoptotic effects. To investigate if this represents a general feature of orthohantaviruses, we analysed the capacity of six different orthohantaviruses - belonging to three distinct phylogroups and representing both pathogenic and non-pathogenic viruses - to inhibit apoptosis in infected cells. Primary human endothelial cells were infected with ANDV, HTNV, the HFRS-causing Puumala virus (PUUV) and Seoul virus, as well as the putative non-pathogenic Prospect Hill virus and Tula virus. Infected cells were then exposed to the apoptosis-inducing chemical staurosporine or to activated human NK cells exhibiting a high cytotoxic potential. Strikingly, all orthohantaviruses inhibited apoptosis in both settings. Moreover, we show that the nucleocapsid (N) protein from all examined orthohantaviruses are potential targets for caspase-3 and granzyme B. Recombinant N protein from ANDV, PUUV and the HFRS-causing Dobrava virus strongly inhibited granzyme B activity and also, to certain extent, caspase-3 activity. Taken together, this study demonstrates that six different orthohantaviruses inhibit apoptosis, suggesting this to be a general feature of orthohantaviruses likely serving as a mechanism of viral immune evasion.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30696898      PMCID: PMC6351540          DOI: 10.1038/s41598-018-37446-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  72 in total

1.  Evolutionary diversification of protein-coding genes of hantaviruses.

Authors:  A L Hughes; R Friedman
Journal:  Mol Biol Evol       Date:  2000-10       Impact factor: 16.240

2.  Hantavirus infections in Europe.

Authors:  Jan Clement; Norbert Lameire; Els Keyaerts; Piet Maes; Marc Van Ranst
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

Review 3.  A time to kill: viral manipulation of the cell death program.

Authors:  Stewart Hay; George Kannourakis
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

4.  Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells.

Authors:  J B Sundstrom; L K McMullan; C F Spiropoulou; W C Hooper; A A Ansari; C J Peters; P E Rollin
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  High levels of viremia in patients with the Hantavirus pulmonary syndrome.

Authors:  M Terajima; J D Hendershot; H Kariwa; F T Koster; B Hjelle; D Goade; M C DeFronzo; F A Ennis
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

Review 6.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

7.  Hantaan virus infection of human endothelial cells.

Authors:  M N Pensiero; J B Sharefkin; C W Dieffenbach; J Hay
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme.

Authors:  C A Ray; R A Black; S R Kronheim; T A Greenstreet; P R Sleath; G S Salvesen; D J Pickup
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

Review 9.  Hantavirus infections in Europe.

Authors:  Olli Vapalahti; Jukka Mustonen; Ake Lundkvist; Heikki Henttonen; Alexander Plyusnin; Antti Vaheri
Journal:  Lancet Infect Dis       Date:  2003-10       Impact factor: 25.071

10.  Long-lived memory T lymphocyte responses after hantavirus infection.

Authors:  Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

View more
  7 in total

Review 1.  Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?

Authors:  Alison M Kell
Journal:  J Mol Biol       Date:  2021-09-04       Impact factor: 5.469

2.  MAIT cell activation is associated with disease severity markers in acute hantavirus infection.

Authors:  Kimia T Maleki; Johanna Tauriainen; Marina García; Priscilla F Kerkman; Wanda Christ; Joana Dias; Julia Wigren Byström; Edwin Leeansyah; Mattias N Forsell; Hans-Gustaf Ljunggren; Clas Ahlm; Niklas K Björkström; Johan K Sandberg; Jonas Klingström
Journal:  Cell Rep Med       Date:  2021-03-16

Review 3.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

4.  Hantavirus inhibits apoptosis by preventing mitochondrial membrane potential loss through up-regulation of the pro-survival factor BCL-2.

Authors:  Carles Solà-Riera; Marina García; Hans-Gustaf Ljunggren; Jonas Klingström
Journal:  PLoS Pathog       Date:  2020-02-07       Impact factor: 6.823

5.  In Vitro Anti-Orthohantavirus Activity of the High-and Low-Molecular-Weight Fractions of Fucoidan from the Brown Alga Fucus evanescens.

Authors:  Natalia V Krylova; Artem S Silchenko; Anastasia B Pott; Svetlana P Ermakova; Olga V Iunikhina; Anton B Rasin; Galina G Kompanets; Galina N Likhatskaya; Mikhail Y Shchelkanov
Journal:  Mar Drugs       Date:  2021-10-15       Impact factor: 5.118

Review 6.  Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus-associated syndromes.

Authors:  J Klingström; A Smed-Sörensen; K T Maleki; C Solà-Riera; C Ahlm; N K Björkström; H G Ljunggren
Journal:  J Intern Med       Date:  2019-02-17       Impact factor: 8.989

7.  Isolation and Genetic Characterization of Puumala Orthohantavirus Strains from France.

Authors:  Johann Vulin; Séverine Murri; Sarah Madrières; Maxime Galan; Caroline Tatard; Sylvain Piry; Gabriele Vaccari; Claudia D'Agostino; Nathalie Charbonnel; Guillaume Castel; Philippe Marianneau
Journal:  Pathogens       Date:  2021-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.